World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 5591739

Number of visits today: 2176

Number of downloads: 3554890

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNALS

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (750)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (1013) | Core Tip (687) | Full Article (HTML) (2184) | Full Article (PDF)-515K (254) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (4277) | Similar Articles (1881) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (1027) | Core Tip (740) | Full Article (HTML) (3477) | Full Article (PDF)-707K (280) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (5670) | Similar Articles (1715) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines For Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (1013) | Core Tip (702) | Full Article (HTML) (2689) | Figures (1-2) (319) | Tables (1-3) (306) | Full Article (PDF)-857K (293) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (5515) | Similar Articles (1715) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1114) | Core Tip (702) | Full Article (HTML) (6285) | Figures (1-3) (329) | Tables (1-2) (390) | Full Article (PDF)-880K (543) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (37) | Total Visits (9552) | Similar Articles (1785) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1111) | Core Tip (689) | Full Article (HTML) (4136) | Figures (1-4) (281) | Tables (1-2) (324) | Full Article (PDF)-862K (510) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (7211) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1293) | Core Tip (736) | Full Article (HTML) (2344) | Full Article (PDF)-510K (233) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (4751) | Similar Articles (223) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345